Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,636.73
(
-1.18%
)
US TECH 100
23,889.60
(
-1.01%
)
Dow Jones
46,260.81
(
-1.56%
)
Brent Oil
105.79
(
5.11%
)
Bitcoin
71,210.04
(
-3.70%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 87555

Tuesday, 12/22/2009 12:47:30 AM

Tuesday, December 22, 2009 12:47:30 AM

Post# of 257253
ACHN’s VC shareholders did some heavy selling on Dec 16-18, immediately after ACHN (prematurely) reported data from the ACH-1625 phase-1b trial. The total amount sold by three VC shareholders on Dec 16-18 was about 1.75M shares worth about $5.8M:

http://sec.gov/Archives/edgar/data/1070336/000101297509000358/xslF345X03/edgar.xml
http://sec.gov/Archives/edgar/data/889232/000118143109057864/xslF345X03/rrd260348.xml
http://sec.gov/Archives/edgar/data/1033508/000093244009000720/xslF345X03/edgar.xml

No further investigation is needed to understand why ACHN jumped the gun on reporting data from the first phase-1b cohort.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now